-transparent.png){kind=logo}
BACKGROUND Specific immunotherapy treatment in allergic diseases involves a risk of systemic side effects. A double-blind, placebo-controlled study was performed in 45 patients allergic to pollen to determine whether pretreatment with loratadine could reduce the number and severity of systemic reactions during the dose-increase phase of cluster immunotherapy. METHODS The patients received cluster immunotherapy with a standardized birch (Betula verrucosa) or grass (Phleum pratense) pollen extract adsorbed to aluminum hydroxide. The immunotherapy schedule involved seven visits and 14 injections to reach a maintenance dose of 100,000 standardized quality units. Loratadine, 10 mg, or placebo tablets were administered 2 hours before the first injection at each visit. RESULTS A total of 720 injections were given (309 injections in 21 patients receiving loratadine and 411 injections in 24 patients receiving placebo). The median numbers of injections to reach maintenance dose were 15 (range, 14 to 18) in the loratadine group and 16 (range, 14 to 23) in the placebo group (p = 0.037). The numbers of patients with systemic reactions were seven (33%) and 19 (79%) in the loratadine and placebo groups, respectively (p = 0.002). Twenty-five reductions caused by systemic reactions were observed in the placebo group in contrast to nine in the loratadine group (p = 0.047). No life-threatening systemic reactions were observed in either group. Systemic reactions were, however, more severe in the placebo group, mainly because of a significantly higher incidence of urticaria (10 vs 1, p = 0.022). CONCLUSIONS Pretreatment with loratadine seems to reduce both the number and severity of systemic reactions in specific cluster immunotherapy.
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
November 1996,
European journal of anaesthesiology,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
March 2005,
European journal of anaesthesiology,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
May 1996,
Chest,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
May 2003,
The Journal of allergy and clinical immunology,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
October 2004,
Digestive diseases and sciences,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
October 1992,
Allergy,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
January 1996,
Journal of investigational allergology & clinical immunology,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
February 2014,
Veterinary dermatology,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
January 1960,
Acta anaesthesiologica Scandinavica,
L Nielsen, and
C R Johnsen, and
H Mosbech, and
L K Poulsen, and
H J Malling
June 1999,
British journal of anaesthesia,
